Brief: Zim Laboratories Signs Pact With Brazil's Hypera Pharma
19/08/2020 08:54
Aug 19 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* SIGNS PACT WITH BRAZIL BASED HYPERA PHARMA GROUP
* ZIM LABORATORIES - ENTERS EXCLUSIVE LICENSING PACT WITH
HYPERA
FOR MARKETING VITAMIN D3 STRIPS
Source text for Eikon: ID:nBSE4zdn5N
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia